Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

Clinical trial NCT02406651 · COMPLETED

Trial details

NCT number: NCT02406651
Sponsor: EVIVE Biotechnology
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Graft vs Host Disease

Start date: 2016-05-12
Primary completion: 2019-04-09
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.